28 Stories, most recent news story added Fri Nov 27, 4:55 am ET
Human life expectancy may see a hockey stick growth curve in the coming years as a result of leaps made in fields such as molecular nanotechnology, gene therapy, robotics, and regenerative medicine. Seizing the potential for radical longevity, an effort dubbed the "Manhattan Beach Project", is a focused and targeted “all-out assault on the world’s biggest killer- aging," according to its founder ...
Image Caption: This image shows the effect of gene therapy combined with cytotoxic agents in E spheroids derived from breast cancer cell line MCF-7. A. Control; B. Doxorubicin 10nm, C. Paclitaxel 10nm, D. Docetaxel 10nm, combined with gene E. Credit: University of Granada
( University of Granada ) The gene in question is a suicide gene, called "gene E," which leads to the death of tumor cells derived from breast, lung and colon cancer, and prevents their growth. Chemotherapy, radiotherapy and surgery show "limited" results in advanced stages of cancer, so the kind of gene therapy proposed by the scientists of the UGR is a huge breakthrough in cancer treatment.
Around the world, there are more than 1,500 gene therapy trials going on to treat everything from Parkinson's to blindness to clogged arteries. Could the key to healing be in the body's building blocks?
( The Mount Sinai Hospital / Mount Sinai School of Medicine ) Mount Sinai School of Medicine is one of 12 sites nationwide participating in the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease. The study is the first multicenter neurosurgical intervention in Alzheimer's research in the US.
Researchers are preparing for the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease. The study, the first multicenter neurosurgical intervention in Alzheimer's research in the U.S., utilizes a viral-based gene transfer system, CERE-110, that makes Nerve Growth Factor (NGF), a naturally occurring protein that helps maintain nerve cell survival in the brain.
AMSTERDAM, November 18 /PRNewswire-FirstCall/ -- - Glybera(R) Clinical Data Presented at Meeting of American Heart Association Amsterdam Molecular Therapeutics (EuroNext Amsterdam: AMT), a leader in the field of human gene therapy, today provides its non-audited business update in compliance with the EU transparency directive.
Nov. 15 (Bloomberg) -- A gene linked to breast cancer in 1 in 10 Jewish women may raise the risk of heart ailments, says a study in mice using gene therapy to improve cardiac function.
After years of complications and high-profile setbacks, a series of small but intriguing advances has suggested that gene therapy may hold real future potential for treatment